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Virus infections trigger metabolic changes in host
cells that support the bioenergetic and biosynthetic
demands of viral replication. Although recent studies
have characterized virus-induced changes in host
cell metabolism (Munger et al., 2008; Terry et al.,
2012), the molecular mechanisms by which viruses
reprogram cellular metabolism have remained
elusive. Here, we show that the gene product of
adenovirus E4ORF1 is necessary for adenovirus-
induced upregulation of host cell glucose meta-
bolism and sufficient to promote enhanced glycol-
ysis in cultured epithelial cells by activation of MYC.
E4ORF1 localizes to the nucleus, binds to MYC,
and enhances MYC binding to glycolytic target
genes, resulting in elevated expression of specific
glycolytic enzymes. E4ORF1 activation of MYC
promotes increased nucleotide biosynthesis from
glucose intermediates and enables optimal adeno-
virus replication in primary lung epithelial cells. Our
findings show how a viral protein exploits host cell
machinery to reprogram cellular metabolism and
promote optimal progeny virion generation.
INTRODUCTION
Similar to infection with certain other viruses (Diamond et al.,
2010; Munger et al., 2008; Vastag et al., 2011), adenovirus
infection increases host cell glycolytic metabolism even in the
presence of ample oxygen for oxidative metabolism, thusmirror-
ing the Warburg effect in cancer (Fisher and Ginsberg, 1957;
Warburg, 1956). Adenoviral proteins and tumor cell mutations694 Cell Metabolism 19, 694–701, April 1, 2014 ª2014 Elsevier Inc.are known to converge in perturbingmany of the samemolecular
players to execute their programs of growth deregulation and
limitless propagation (O’Shea, 2005). Consequently, adenovi-
ruses can be used as a genetically tractable tool to gain new
insights into the complex networks that underlie both this
metabolic switch and aberrant cellular replication. Because
both adenoviruses and oncogenes rewire cellular metabolism
to satisfy the demands of increased proliferation of virions
and daughter cells, respectively, studying the mechanism by
which adenovirus reprograms host cell glucose metabolism
may reveal key nodes important for upregulation of anabolic
glucose metabolism in cancer.RESULTS
Adenovirus Infection Increases Glycolytic Metabolism
of Host Cells
To confirm that adenovirus infection enhances glycolytic meta-
bolism of cultured epithelial cells, we infected the nontumori-
genic breast epithelial cell line MCF10A with a wild-type (WT)
strain of adenovirus 5 (AD). AD WT infection robustly increases
glycolytic metabolism of MCF10A cells, visibly evident by acidi-
fication of the culture media and yellowing of the pH indicator
phenol red (Figure 1A) and quantifiably evident by elevated
glucose consumption and lactate production rates over multiple
days postinfection (Figures 1B and 1C). MCF10A cells infected
with AD WT also exhibited a dramatic reduction in oxygen
consumption rate (Figure 1D), suggesting decreased reliance
on oxidative phosphorylation. These observed changes in
MCF10A metabolism upon AD WT infection were not due to dif-
ferences in cell number or apoptosis (Figure S1 available online).
To identify adenoviral gene elements necessary for upregu-
lation of glycolytic metabolism in host cells, we tested AD
deletion mutants for their competence to alter glucose con-













Figure 1. The E4 Region Is Necessary for Adenovirus-Induced Enhancement of Glucose Metabolism in Host Cells
(A) MCF10A cells were either mock infected or infected with ADWT or AD DE4 virus for the indicated times. Yellowing of the pH indicator dye phenol red depicts
media acidification from enhanced lactic acid production by the AD WT-infected cells. The average cell numbers at 72 hr for mock, WT, and DE4 infections are
5.8 3 106, 3.2 3 106, and 3.8 3 106, respectively.
(B–D) MCF10A cells were infected for the indicated times, andmetabolic measurements were taken. Glucose consumption rates (B), lactate production rates (C),
and oxygen consumption rates (D) from cells infected with AD WT or AD DE4 were measured in triplicate samples.
(E) Metabolic measurements from MCF10A cells constitutively expressing a vector control or the full E4 region.
Error bars denote SEM (n = 3). *p < 0.05; **p < 0.01; n.s., not significant.
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entire E4 early transcription unit region (AD DE4) failed to
increase glycolytic metabolism and decrease respiration in
infected cells (Figures 1A–1D). Notably, stable expression of
the entire AD E4 region in MCF10A cells was sufficient to
increase glucose consumption and lactate production rates
but had no effect on oxygen consumption rates (Figure 1E).
Together, these data suggest that the E4 region is necessary
for adenovirus-induced enhancement of host cell glucose meta-
bolism and is sufficient to promote increased glycolysis, but not
decreased respiration, in MCF10A cells.
Adenoviral Gene Product E4ORF1 Is Sufficient
to Promote Increased Glucose Metabolism
in Epithelial Cells
The E4 region encodes at least six distinct polypeptides, defined
as E4 open reading frames (ORFs) 1–6 (Figure S2A), which regu-
late viral DNA synthesis and viral gene expression (Javier, 1994).
To determine which E4ORF is responsible for the observed
increase in glycolytic flux in response to gene expression from
the E4 region, each of five of the E4ORFs was individually
expressed in MCF10A cells (Figure 2A). The splice variant
E4ORF6/7 was not expressed, and its role in these metabolic
changes cannot be excluded. By measuring glucose consump-
tion and lactate production rates, we found that only E4ORF1Cexpression, by itself, was sufficient to increase cellular glycolytic
flux (Figure 2B).
Among the E4ORFs individually expressed in Figure 2A,
E4ORF1 and E4ORF6 were expressed at lower levels than the
other ORFs. Because ORF6 plays a role in facilitating viral
gene expression from the onset of late phase (Dix and Leppard,
1993), we reasoned that coexpressing ORF6 may enhance
expression or stability of ORF1. Indeed, when both ORF1 and
ORF6 were expressed together in MCF10A cells, ORF1 protein
levels were robustly elevated, and we found that ORF1 and
ORF6 physically interacted (Figure S2B). Because these data
suggest that E4ORF6 binds to and stabilizes E4ORF1, we stably
coexpressed E4ORF6 along with E4ORF1 in all subsequent
experiments.
AD E4ORF1 encodes a 14 kDa polypeptide previously shown
to induce transformation and enhance tumorigenicity of rat
embryonic fibroblasts (Javier, 1994). The tumorigenic potential
of E4ORF1 depends on a C-terminal PDZ domain binding motif
that mediates binding to a select group of cellular PDZ domain-
containing proteins (Chung et al., 2007) and activation of phos-
phatidylinositol 3-kinase (PI3K) and AKT (Frese et al., 2003).
We initially hypothesized that E4ORF1 increases glycolytic flux
through activation of PI3K signaling. However, a tetracycline-
inducible truncation mutant of E4ORF1 lacking the PDZ binding









Figure 2. The Adenoviral Gene Product E4ORF1 Is Sufficient to Promote Increased Glucose Metabolism in Cultured Epithelial Cells
(A) Immunoblotting of lysates from MCF10A cells stably expressing flag-tagged E4 ORF1, ORF2, ORF3, ORF4, or ORF6. The top panel was probed with FLAG
antibody, and the bottom panel was probed with tubulin antibody to control for loading. VECT, vector.
(B) Glucose consumption and lactate production rates from MCF10A cells stably expressing the flag-tagged ORFs indicated in (A).
(C) Immunoblotting of lysates from MCF10A cells stably expressing HA-tagged E4ORF6 along with an inducible empty vector, flag-tagged ORF1 WT, or flag-
tagged ORF1DPDZ. Briefly, the cells were treated with 1 mg/ml doxycycline for 24 hr and subsequently starved for 24 hr in serum-free media with 1mg/ml
doxycycline. To test the activation of PI3K, lysates were probed for phospho-Ser473-AKT; total AKT was used as a loading control, and FLAG was used to
indicate induced ORF1 expression.
(D) Cells described in (C) were induced to express flag-tagged ORF1WT or flag-tagged ORF1DPDZ, and glucose consumption and lactate production rates were
measured in full serum conditions.
Error bars denote SEM (n = 3). *p < 0.05; **p < 0.01.
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cells when acutely expressed following addition of doxycycline
(Figures 2C and 2D). These results suggest that E4ORF1 en-
hances cellular glycolytic metabolism in a PI3K-independent
manner.
MYC Transcriptional Activity Is Enhanced by E4ORF1
Expression and Adenovirus Infection
To gain insight into the mechanism by which E4ORF1 promotes
increased glycolytic flux, we conducted a global microarray
analysis of changes in whole-genome expression in E4ORF6-ex-
pressing MCF10A cells that were induced to express E4ORF1
versus an empty vector control. Using gene set enrichment
analysis (GSEA), we found that MYC-regulated genes were
significantly enriched in cells expressing E4ORF1 (Table S1;
Figure S3A, p < 0.001). In addition, gene sets with increased
MYC activity were also enriched when compared to all gene
sets (Figure S3B, p < 0.001). It was recently reported that tumor
viruses rewire host cell transcriptome networks (Rozenblatt-
Rosen et al., 2012). Comparing our E4ORF1 gene expression
signature to that of E4ORF1 in IMR90 human diploid fibroblasts,696 Cell Metabolism 19, 694–701, April 1, 2014 ª2014 Elsevier Inc.we found that MYC gene sets are coordinately regulated by
E4ORF1 in both contexts (Figure S3C, p < 0.001). Analysis of
MYC gene sets relative to all gene sets confirmed enrichment
of MYC gene sets in both breast epithelial and primary fibroblast
systems (Figure S3D).
To investigate whether MYC is indeed affected by E4ORF1
expression in MCF10A cells, as suggested from our enrichment
analysis, we first examined localization of MYC in E4ORF1-
versus empty vector-expressing cells. As shown in Figure 3A,
we found that nuclear MYC protein levels are elevated in
E4ORF1-expressing cells. Additionally, E4ORF1 physically as-
sociates with MYC and E4ORF6 in the nuclear fraction (Fig-
ure 3B). Because E4ORF6 is unable to interact with MYC in the
absence of E4ORF1 expression, binding between MYC and
the E4ORF proteins depends on interaction with E4ORF1 (Fig-
ure 3B). Because MYC is a transcription factor that regulates
energy metabolism through direct activation of metabolic
genes (Osthus et al., 2000; Shim et al., 1997), we reasoned
that E4ORF1 expression and binding to MYC may enhance
MYC activation of glycolytic genes. To test this hypothesis, we
measured, by chromatin immunoprecipitation and quantitative
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E4ORF1 Promotion of Anabolic Glucose MetabolismPCR (ChIP-qPCR), MYC binding to candidate glycolytic target
genes. As shown in Figure 3C, MYC binding to glycolytic target
genes is elevated in cells induced to express E4ORF1 versus
the empty vector control (Fisher’s method, p < 0.001). Addition-
ally, E4ORF1 itself also binds to MYC glycolytic target genes
(Fisher’s method, p < 0.001) (Figures 3C and S3E).
Previous findings suggest that the oncogenic potential of
E4ORF1 depends not only on the PDZ binding motif but also
on a second protein element called region 2 (Chung et al.,
2007). We generated and tested a series of E4ORF1 region 2
point mutants for their capability to enhance glycolytic meta-
bolism (data not shown). One region 2 mutant, E4ORF1 D68A,
exhibits a severe defect in cellular transformation, retains the ca-
pacity to bind to cellular PDZ proteins, but fails to stimulate the
PI3K pathway (Chung et al., 2007). We generated MCF10A cells
that inducibly express E4ORF1 D68A or E4ORF1 WT at similar
protein expression levels (Figure 3A). The D68A point mutation
in E4ORF1 abolished the increased glycolytic flux observed
with E4ORF1 WT expression (Figure 3D). Additionally, D68A
mutation impaired the ability of E4ORF1 to elevate nuclear
MYC levels (Figure 3A), interact with nuclear MYC (Figure 3B),
bind to MYC glycolytic target genes (Fisher’s method, p =
0.06) (Figures 3C and S3E), and promote increasedMYC binding
to glycolytic target genes (Fisher’s method, p = 0.09) (Figures 3C
and S3E).
To investigate whether the observed increase in MYC binding
to glycolytic target genes in E4ORF1-expressing cells results in
increased expression of glycolytic genes, we measured relative
mRNA levels of glycolytic target genes in cells expressing
E4ORF1 WT and E4ORF1 D68A versus empty vector. Expres-
sion of the first two rate-limiting and glycolysis-promoting
(as opposed to gluconeogenesis) enzymes in the glycolytic
pathway, Hexokinase 2 (HK2) and Phosphofructokinase 1
(PFKM), was significantly elevated in E4ORF1-expressing cells
(Figure 3E). Additionally, E4ORF1 D68A-expressing cells ex-
pressed lower levels of HK2 and PFKM mRNAs than E4ORF1
WT-expressing cells (Figure 3E). Paradoxically, although MYC
binding to the GAPDH and LDHA gene loci was significantly
elevated in E4ORF1-expressing cells (Figures 3C and S3E),
no increase in GAPDH and LDHA mRNA levels was observed.
However, because the D68A mutation impaired E4ORF1’s
capability to both activate MYC-induced transcription of HK2
and PFKM and promote increased glycolysis in MCF10A
cells, these data lend further support to the model that
E4ORF1 promotes enhanced glycolysis through binding to
MYC and activation of MYC-induced transcription of glycolytic
genes.
To determine whether E4ORF1 promotes MYC-induced tran-
scription of glycolytic genes during adenovirus infection, we
generated a mutant of AD that contains the D68A amino acid
alteration in E4ORF1 (AD ORF1 D68A) and compared its effects
to WT virus (AD WT) on mediating MYC transcription of meta-
bolic genes. ADWT infection of primary normal human bronchial
epithelial (NHBE) cells leads to enrichment of MYC binding to its
glycolytic target genes, HK2 and PFKM (Figures 3F and S3F).
This elevated binding is abrogated when the cells are instead
infected with AD ORF1 D68A (Figures 3F and S3F). Additionally,
cells infected with AD WT, but not AD ORF1 D68A, exhibit
increased expression of HK2 and PFKM1 mRNA (Figure 3G).CTogether, these data suggest that E4ORF1 modulates MYC
transcription of glycolytic genes during adenovirus infection.
E4ORF1 Activation of MYC Promotes Anabolic Glucose
Metabolism and Optimal Adenovirus Replication
To examine whether the increase in host cell glycolysis accom-
plished by E4ORF1 activation ofMYC is important for adenovirus
replication, we first prevented MYC activation in adenovirus-
infected primary NHBE cells by small hairpin RNA (shRNA)-
mediated knockdown of MYC expression. MYC knockdown
diminished the acidification of the growth medium (Figure 4A)
and blocked the elevation in glucose consumption and lactate
production rates conferred by adenovirus infection (Figure 4B).
Moreover, the plaque-forming capacity of virus harvested from
NHBE cells expressing MYC shRNA was reduced by an order
of magnitude when compared to virus harvested from cells
expressing a scrambled shRNA control (Figure 4C). These data
suggest that MYC-activated metabolic changes contribute to
optimal adenovirus replication in primary cells.
To specifically address whether E4ORF1-induced activation
of MYC is necessary for optimal adenovirus replication, we
infected NHBE cells with AD ORF1 D68A and compared the
effects of this mutant virus to those of ADWT on cell metabolism
and virus replication. Similar to AD DE4 (Figures 1A–1C), AD
ORF1 D68A was unable to enhance glycolytic flux of infected
cells (Figures 4D and 4E). Progeny virus harvested from AD
ORF1 D68A-infected NHBE cells formed significantly fewer
plaques in HeLa cells than progeny virus harvested from AD
WT-infected cells (Figure 4F). To determine whether the
observed replication deficiency of the AD ORF1 D68A mutant
virus was due to its inability to activate PI3K or enhance glyco-
lytic flux, we also compared the effects of AD WT versus AD
ORF1 D68A infection on virus replication inMCF10A cells, a rela-
tively more glycolytic cell line than NHBE cells with low basal
PI3K activation (Figures 2C, S4A, and S4B). Progeny virus
harvested from AD ORF1 D68A-infected MCF10A cells formed
a similar number of plaques in HeLa cells than progeny virus
harvested from AD WT-infected cells (Figure S4C), suggesting
that the increased glycolysis in MCF10A cells rescued the
replication deficiency of the AD ORF1 D68A virus. Together,
these data imply that E4ORF1-induced activation of MYC and
enhancement of glycolytic flux promote optimal adenovirus
replication in host cells.
Because adenovirus is a nonenveloped DNA virus, we hypo-
thesized that E4ORF1/MYC-enhanced glycolytic metabolism
may contribute to adenovirus replication by enabling increased
nucleotide biosynthesis from glucose metabolites. To test this
hypothesis, we labeled NHBE cells with [1,2-13C]glucose and
measured the fraction of 13C-labeled nucleotides in AD WT-
versus AD ORF1D68A-infected NHBE cells. NHBE cells infected
with AD WT, but not AD ORF1D68A, exhibited a robust increase
in the incorporation of 13C from glucose into nucleotides
(Figure 4G). AD WT-infected cells also showed increased
levels of nucleotides and nucleotide metabolism intermediates
relative to AD ORF1D68A-infected cells and mock-infected
cells (Figure S4D). To probe whether the increased nucleotide
biosynthesis from glucose metabolites in adenovirus-infected
cells contributes to DNA replication, we labeled NHBE cells







Figure 3. E4ORF1 Enhances MYC Transcriptional Activation of Glycolytic Genes
(A) Immunoblotting (IB) of nuclear and cytoplasmic fractions from HA-tagged E4ORF6-expressing MCF10A cells induced to express vector control, flag-tagged
E4ORF1 (ORF1WT), or the flag-tagged E4ORF1 D68A point mutant (ORF1D68A). Lysates were clonally selected to have equal molar amounts of E4ORF1
proteins.
(B) Immunoprecipitations (IP) from nuclear fractions of HA-tagged E4ORF6-expressing MCF10A cells expressing FLAG-GFP or induced to express flag-tagged
ORF1WT or flag-tagged ORF1D68A.
(C) Heatmap depicts the level of MYC binding to the indicated genes by ChIP-qPCR in HA-tagged E4ORF6-expressing MCF10A cells induced to express vector
control, flag-tagged ORF1WT, or flag-tagged ORF1D68A using antibodies toward MYC, FLAG, or IgG as a negative control. RLP32 is used as a negative control
locus for MYC. The ChIP values represent the amount of immunoprecipitated DNA in each sample relative to the total amount of input chromatin (equivalent to 1)
(legend continued on next page)
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E4ORF1 Promotion of Anabolic Glucose MetabolismDNA in mock-infected, AD WT-infected, and AD ORF1D68A-
infected cells. As shown in Figure S4E, AD WT infection, but
not AD ORF1D68A infection, resulted in increased incorporation
of labeled glucose carbons into DNA. These results suggest that
E4ORF1-induced activation of MYC during adenovirus infection
leads to increased nucleotide biosynthesis from glucose for
elevated DNA replication, implying potentially increased flux of
glucose metabolites through the pentose phosphate pathway
(PPP) to generate ribose-5-phosphate. Consistent with this
hypothesis, we found that mRNA expression levels of RPIA
and RPE, enzymes that regulate carbon exchange reactions
in the nonoxidative arm of the PPP, are significantly increased
in cells expressing E4 ORF1 WT, but not E4 ORF1 D68A
(Figure S4F). Moreover, in the context of virus infection, we
also observed that RPIA and RPE mRNA levels are elevated
in NHBE cells infected with AD WT, but not AD ORF1D68A
(Figure 4H). Together, these data support a model whereby
E4ORF1-induced activation of MYC during adenovirus infection
leads to increased flux through glycolysis and potentially through
the nonoxidative arm of the PPP to provide nucleotides for
adenoviral DNA replication (Figure 4I).
DISCUSSION
This study presents a molecular mechanism by which a virus
reprograms host cell metabolism to promote replication: adeno-
virus E4ORF1-induced activation of MYC. However, the precise
mechanism by which E4ORF1 enhances MYC-dependent
transcription of metabolic genes remains to be determined.
Our results suggest that E4ORF1 binds to MYC and leads to
increased MYC localization to glycolytic target genes. E4ORF1
may promote MYC activation by increasing affinity of MYC
for specific metabolic target genes, promoting binding of
chromatin-remodeling machinery to enhance MYC-induced
transcription, or simply by enhancing MYC protein stability. It
will be interesting for future studies to determine both how
E4ORF1 induces MYC-dependent transcription of metabolic
genes during adenovirus infection and whether MYC plays a
role in metabolic reprogramming by other types of viruses.
Although MYC is known to regulate transcription of many
glycolytic genes, our data suggest that E4ORF1-induced activa-
tion of MYC most notably enhances transcription of HK2 and
PFKM during adenovirus infection. Because viruses undergo
selective pressure for efficiency, only key flux-altering enzymes
are likely elevated during infection. Our data suggest that
elevated HK2 and PFKM levels are sufficient to drive the in-
creased glycolysis observed upon E4ORF1 expression. Con-
sistent with this hypothesis, hexokinase activity is elevated
in E4ORF1 but not E4ORF1 D68A-expressing MCF10A cellsand are color coded with a gradient from blue for the minimum through red for the
three replicates. Specific values for percent (%) input can be found in Figure S3E
(D) Relative glucose consumption and lactate production rates from HA-tagged E
or ORF1D68A compared to respective uninduced samples.
(E) Relative mRNA levels of glycolytic genes from HA-tagged E4ORF6-expressi
D68A.
(F) Heatmap representing MYC binding to indicated gene targets by ChIP-qPCR
Specific values for percent (%) input can be found in Figure S3F.
(G) Relative mRNA levels of glycolytic genes from NHBE cells infected with AD W
For (D), (E), and (G), error bars denote SEM (n = 3). *p < 0.05; **p < 0.01.
C(Figure S4G), and during ADWT but not AD ORF1D68A infection
of NHBE cells (Figure S4H). Additionally, stable expression of
HK2, by itself, in MCF10A cells is sufficient to enhance glycolysis
to a similar extent as stable expression of E4ORF1 or MYC
(Figures S4I–S4K). These data suggest that elevated HK2
activity may underlie the increased glycolytic flux induced by
E4ORF1 activation of MYC and that viruses may be useful tools
to reveal key enzymes important for pathway fluxes. However,
further studies are needed to determine whether HK2 elevation
during adenovirus infection is necessary for increased host cell
glycolysis and virus replication.
Although our data suggest that E4ORF1-induced MYC acti-
vation is necessary for increased glycolytic metabolism in AD-
infected cells, another virus-encoded protein (or combination
of viral proteins) is responsible for abrogation of host cell respi-
ration upon adenovirus infection (shown in Figure 1D), which
likely contributes to the greater increase in glycolysis observed
during adenovirus infection versus stable E4ORF1 expression
(Figures 1B and 1C versus Figure 2B). Preliminary data suggest
that host cell mitochondria are intact and membrane potential is
maintained following AD infection, despite the substantially
reduced oxygen consumption rate (data not shown). It will be
interesting to determine the viral components responsible for
this decrease in cellular respiration and whether these viral
components, and this metabolic alteration, also contribute to
adenovirus replication.
Our results support MYC as a key node in promoting cellular
anabolic glucose metabolism. Consistent with our data in
adenovirus-infected cells, recent studies have shown that MYC
activation downstream of oncogenic Kras reprograms tumor
metabolism toward increased glycolysis and shunting of glucose
metabolites toward the nonoxidative arm of the PPP for ribose
generation (Ying et al., 2012) and that MYC upregulation con-
tributes to theWarburg effect in tumors from patients with breast
cancer (Palaskas et al., 2011). MYC-dependent transcription has
also been implicated in metabolic reprogramming toward
increased glycolysis and glutaminolysis to support biosynthesis
during activation of primary T lymphocytes (Wang et al., 2011).
Collectively, our results and these studies indicate that MYC-
dependent transcription of metabolic genes is a general mecha-
nism, active across multiple pathophysiological conditions, by
which cells reprogrammetabolism toward increased anabolism.EXPERIMENTAL PROCEDURES
Measurement of Glucose Consumption Rates and Lactate
Production Rates
Cellular glucose consumption and lactate export rates were measured using
a Nova Biomedical BioProfile Basic Analyzer. Briefly, cells were seeded inmaximum percentage of input. Each square is an independent experiment with
.
4ORF6-expressing MCF10A cells induced to express equal levels of ORF1WT
ng MCF10A cells induced to express empty vector, E4ORF1 WT, or E4ORF1
in NHBE cells infected with AD WT or AD E4ORF1D68A for 4 hr at equal titers.
T or AD D68A for 4 hr at equal titers.














Figure 4. E4ORF1 Activation of MYC Promotes Anabolic Glucose Metabolism and Optimal Adenovirus Replication
(A) AD WT-infected NHBE cells stably expressing a MYC-directed shRNA exhibit less yellowing of the media pH indicator dye phenol red than AD WT-infected
NHBE cells stably expressing a scrambled shRNA control.
(B) Glucose consumption and lactate production rates from NHBE cells expressing scrambled shRNA (dark gray) or MYC shRNA (light gray) 24 hr postinfection
with AD WT versus mock infection.
(C) Progeny virus was harvested from AD WT-infected NHBE cells expressing scrambled shRNA or MYC shRNA, and adenovirus titers were determined using
serial plaque assays on HeLa monolayers.
(D) AD D68A-infected NHBE cells exhibit less yellowing of the media pH indicator dye phenol red than AD WT-infected cells.
(E) Glucose consumption and lactate production rates from NHBE cells mock infected or infected with AD WT or AD D68A.
(F) Progeny virus from AD WT- and AD D68A-infected NHBE cells was harvested, and adenovirus titers were determined as in (C).
(G) NHBE cells mock infected or infected with ADWT or AD D68A were cultured in medium with [1,2-13C]glucose for 24 hr. Extracted metabolites were analyzed
by LC-MS/MS, and the percentage of 13C-labeled nucleotides was compared.
(H) Relative mRNA levels of PPP genes from NHBE cells infected with AD WT or AD D68A for 12 hr at equal titer.
(I) Schematic representation of the shift in glucose metabolism upon infection with adenovirus, in which E4ORF1 binds to MYC and activates MYC-dependent
transcription of metabolic genes to increase glycolytic flux and potential shunting of glucose metabolites into the nonoxidative arm of the PPP (to facilitate ribose
biosynthesis for viral RNA production and DNA replication).
For (B), (C), and (E)–(H), error bars denote SEM (n = 3). *p < 0.05; **p < 0.01.
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would be taken when the cells were subconfluent. Twenty-four hours post-
seeding, the media were refreshed for all cells, and media were added to
empty wells as a blank control. After 24 hr incubation, 1 ml of media was
removed from each sample and the blank control, and media samples were
analyzed in the Nova BioProfile analyzer. Cell number was determined using
a Coulter particle analyzer and used to normalize the calculated rates.
Enrichment Analysis
To identify gene sets enriched in E4ORF1-expressing MCF10A cells, we used
the GSEA algorithm (Subramanian et al., 2005) with pathway annotation700 Cell Metabolism 19, 694–701, April 1, 2014 ª2014 Elsevier Inc.defined by theMolecular Signatures Database (MSigDB) C2 collection (version
2.5) of canonical signaling pathways, cellular processes, chemical and genetic
perturbations, and human disease states. Probe sets were ranked by the
signal-to-noise ratio (SNR) between E4ORF1- and vector-expressing cells
(n = 3 for each condition) and collapsed by the maximum absolute SNR for
each gene. To identify the enrichment of MYC targets in E4ORF1-expressing
cells, we manually curated the MSigDB genes sets associated with increased
or decreasedMYC activity (‘‘Myc up’’ and ‘‘Myc down,’’ n = 26 and 13, respec-
tively). We then ranked all gene sets by average NES and calculated the
probability that ‘‘Myc up’’ and ‘‘Myc down’’ pathways were enriched using a
GSEA-style enrichment analysis.
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A total of 43 106 NHBE cells were infected at 10 plaque-forming units (pfu)/cell
for 5 days. Cells from the entire plate were harvested by pipetting up and
down, collected in a conical tube, and spun down at 3 K for 10 min. Pellet
was resuspended with 100 ml 10 mM Tris (pH 7.4). Cells were lysed by freeze,
thaw, and vortexing vigorously. Supernatant was harvested as virus stocks for
plaque assays. For viral replication assays, HeLa cells were grown to 80%
confluence and subsequently infected with 10-fold dilutions of virus stocks.
Dilutions of virus stocks were added to cells in duplicate. Plates were then
overlayed with Dulbecco’s modified Eagle’s medium (DMEM) containing
0.7% agarose. Plaques were counted when visible to the naked eye, typically
5 days. Titer was calculated in pfu per milliliter.
Statistical Analysis
All data are presented as mean ± SEM. As noted in figure legends, data were
analyzed by two-sample equal variance Student’s t test with two-tailed
analysis.
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